Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Cancer Medicine|September 18, 2020
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer PatientsDouglas Tremblay, Carina Seah, Thomas Schneider, et al.The Journal of Infectious Diseases|August 30, 2020
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2Svenja Weiss, Jéromine Klingler, Catarina Hioe, et al.Proceedings of the National Academy of Sciences of the United States of America|February 17, 2021
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopesAlec W Freyn, Julianna Han, Jenna J Guthmiller, et al.Transfusion|October 30, 2020
Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2Freddy T Nguyen, Tayler van den Akker, Kimberly Lally, et al.Science Translational Medicine|June 3, 2021
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopesJenna J Guthmiller, Julianna Han, Lei Li, et al.Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysisStephen A Klassen, Jonathon Senefeld, Patrick W Johnson, et al.Mayo Clinic Proceedings|May 7, 2021
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysisStephen A Klassen, Jonathon W Senefeld, Patrick W Johnson, et al.Vaccine|June 30, 2026
Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adultsSean T H Liu, Irene González-Domínguez, Amparo Martínez-Pérez, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humansFatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.Nature Medicine|May 14, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humansFatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.Pageof 3